News Sentiment

MRKR sentiment intelligence

Marker Therapeutics Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 55 Balanced news tone 49 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 1.51 Week of 10 Jul 2026
Weighted tone 55/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

72/100 classification confidence.

Company focus 41

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

+2.7% over one week, +9.4% over four weeks, trend inactive, and below fair value.

Latest direct headline Positive

Wainwright reiterates Buy on Marker Therapeutics stock, $10 target

Market Reaction

Balanced read

61/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 72/100 classification
One-week reaction 2.7% Price confirming higher
Trend fit Trend inactive 9.4% over four weeks
Fair value -45.1% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 15
Neutral 30
Negative 4

Relevance

Why the article matched

Direct first
Direct company coverage 41
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
TradingView 12
Market source 7
TradingKey 7
Stock Titan 3
simplywall.st 3
Investing.com 2
Investing.com Canada 2
DonanımHaber 2

Event Lens

What the news is about

Classified themes
Earnings 17
Market update 17
Analyst action 7
Balance sheet 5
Guidance 2
Deals and strategy 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-49 of 49
TradingKey Direct company coverage

TradingKey

This page provides an overview of Marker Therapeutics Inc. (MRKR) on the TradingKey platform. It displays basic financial information like market capitalization, current stock price, and price change. The page also offers sections for financials, discussions, and analysis, along

Tone
Neutral 50/100
Event
Market update
Published
12 May 2026 07:40
Source
TradingKey
TradingView Direct company coverage

Number of shareholders of Marker Therapeutics, Inc. – NASDAQ:MRKR

This article provides details regarding the number of shareholders for Marker Therapeutics, Inc. (NASDAQ: MRKR). It appears to be a stub or a data point from a financial platform, indicating the company's stock market presence on Nasdaq. The content does not include the actual nu

Tone
Neutral 50/100
Event
Market update
Published
11 May 2026 02:09
Source
TradingView
MSN Direct company coverage

Marker Therapeutics, Inc. (MRKR) reports Q4 loss, tops revenue estimates

Marker Therapeutics, Inc. (MRKR) announced a fourth-quarter loss per share that was narrower than the Zacks Consensus Estimate, while its revenue exceeded expectations. The biotechnology company reported progress in clinical trials for its multi-tumor antigen-specific T cell (MTA

Tone
Positive 66/100
Event
Earnings
Published
08 May 2026 05:09
Source
MSN
Stock Titan Direct company coverage

Marker Therapeutics (NASDAQ: MRKR) holders back share increase but reject voting change

Marker Therapeutics (NASDAQ: MRKR) stockholders approved a Charter Amendment to significantly increase the authorized common shares from 30 million to 130 million, providing the company with more flexibility for future equity issuances. While this key proposal passed, along with

Tone
Neutral 50/100
Event
Market update
Published
04 May 2026 20:39
Source
Stock Titan
The Globe and Mail Direct company coverage

Marker Therapeutics Shareholders Approve Governance and Capital Changes

Marker Therapeutics shareholders recently re-elected all director nominees, approved executive compensation, and ratified their independent auditor. They also significantly increased the company's authorized common stock from 30 million to 130 million shares, providing flexibilit

Tone
Neutral 50/100
Event
Market update
Published
02 May 2026 14:39
Source
The Globe and Mail
TradingView Direct company coverage

Total debt per share of Marker Therapeutics, Inc. – FWB:GX1

This article displays information regarding the total debt per share of Marker Therapeutics, Inc. (FWB:GX1). The content focuses on financial data for the company's stock on the Frankfurt Stock Exchange. No specific debt figures are presented, but the structure suggests this is a

Tone
Neutral 50/100
Event
Balance sheet
Published
05 Apr 2026 12:40
Source
TradingView
TradingView Direct company coverage

EBITDA per share of Marker Therapeutics, Inc. – FWB:GX1

This article provides access to the EBITDA per share financial data for Marker Therapeutics, Inc. (FWB:GX1) on TradingView. It highlights that the market for GX1 on the Frankfurt Stock Exchange is currently closed with no trades. The content primarily serves as a gateway to finan

Tone
Neutral 50/100
Event
Market update
Published
05 Apr 2026 07:39
Source
TradingView